PharmaShots

MAY 12, 2023

Sanofi Reports P-IIIb Trial (HARMONIE) Results of Nirsevimab for the Prevention of Hospitalizations due to RSV-Related LRTD Date: May 12, 2023 | Tags: Sanofi, Nirsevimab, RSV-Related LRTD, Clinical Trial, P-IIIb, HARMONIE Trial G1 Therapeutics Presents Preliminary Results from P-II Trial of Trilaciclib for Triple-Negative Breast Cancer at ESMO 2023 (..)

FDA 40

FDA Chemotherapy Immunization Hospitals 40

The Checkup by Singlecare

SEPTEMBER 7, 2023

Other GLP-1 receptor agonists (with indication for diabetes) If the price of Mounjaro or insurance coverage is not sustainable, the first move might be to find a GLP-1 drug with a lower price tag or better coverage on an insurance plan. All GLP-1 agonists today are injectable drugs except for Rybelsus, the only oral option.

Insurance 52

Insurance Insurance Coverage FDA Dosage 52

The Checkup by Singlecare

NOVEMBER 2, 2023

The high price tag is a barrier for many people. One example is Farxiga (dapagliflozin) , a brand-name drug approved to treat Type 2 diabetes and lower the risk of cardiovascular death and hospitalization in people with heart failure (when the heart is weak and cannot pump enough blood). This includes Medicare and Medicaid.

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

The Checkup by Singlecare

JANUARY 19, 2023

There may also be skin tags in these areas. Diabetes People with diabetes have a fasting blood sugar of 126 mg/dl or more. People with insulin resistance or prediabetes may not have any symptoms. There may be darkened skin in the armpits or around the neck—this is called acanthosis nigricans.

Immunization 105

Immunization Hospitals Communication 105